Prudential Financial’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $30M | Sell |
163,887
-189,606
| -54% | -$34.9M | 0.04% | 310 |
|
|
2025
Q4 | $62.2M | Sell |
353,493
-85,616
| -19% | -$14M | 0.08% | 198 |
|
|
2025
Q3 | $61.5M | Buy |
439,109
+51,280
| +13% | +$6.93M | 0.07% | 205 |
|
|
2025
Q2 | $48.7M | Sell |
387,829
-32,820
| -8% | -$4.09M | 0.06% | 237 |
|
|
2025
Q1 | $57.6M | Sell |
420,649
-155,627
| -27% | -$22.2M | 0.08% | 191 |
|
|
2024
Q4 | $88.1M | Buy |
576,276
+152,992
| +36% | +$25.8M | 0.12% | 148 |
|
|
2024
Q3 | $82M | Buy |
423,284
+328,707
| +348% | +$68.8M | 0.12% | 161 |
|
|
2024
Q2 | $21.9M | Sell |
94,577
-10,368
| -10% | -$2.25M | 0.03% | 394 |
|
|
2024
Q1 | $22.6M | Sell |
104,945
-24,148
| -19% | -$5.66M | 0.03% | 414 |
|
|
2023
Q4 | $32.8M | Sell |
129,093
-106,717
| -45% | -$26.2M | 0.05% | 311 |
|
|
2023
Q3 | $60.6M | Buy |
235,810
+69,345
| +42% | +$18.5M | 0.09% | 201 |
|
|
2023
Q2 | $47.4M | Sell |
166,465
-114,363
| -41% | -$34M | 0.07% | 249 |
|
|
2023
Q1 | $78.1M | Buy |
280,828
+154,220
| +122% | +$42.7M | 0.12% | 164 |
|
|
2022
Q4 | $35.1M | Buy |
126,608
+122
| +0.1% | +$34.5K | 0.06% | 313 |
|
|
2022
Q3 | $33.8M | Sell |
126,486
-15,408
| -11% | -$3.27M | 0.06% | 301 |
|
|
2022
Q2 | $28.9M | Sell |
141,894
-24,095
| -15% | -$4.93M | 0.05% | 359 |
|
|
2022
Q1 | $35M | Buy |
165,989
+11,661
| +8% | +$2.54M | 0.05% | 353 |
|
|
2021
Q4 | $37.1M | Sell |
154,328
-3,409
| -2% | -$877K | 0.05% | 345 |
|
|
2021
Q3 | $44.6M | Sell |
157,737
-72,264
| -31% | -$23.7M | 0.06% | 280 |
|
|
2021
Q2 | $79.6M | Sell |
230,001
-2,124
| -0.9% | -$643K | 0.11% | 184 |
|
|
2021
Q1 | $64.9M | Sell |
232,125
-256,996
| -53% | -$69.3M | 0.1% | 200 |
|
|
2020
Q4 | $120M | Sell |
489,121
-103,221
| -17% | -$26.6M | 0.2% | 106 |
|
|
2020
Q3 | $168M | Buy |
592,342
+86,988
| +17% | +$24.3M | 0.31% | 67 |
|
|
2020
Q2 | $135M | Buy |
505,354
+1,904
| +0.4% | +$572K | 0.26% | 84 |
|
|
2020
Q1 | $159M | Sell |
503,450
-385,756
| -43% | -$117M | 0.35% | 59 |
|
|
2019
Q4 | $264M | Sell |
889,206
-46,460
| -5% | -$12.9M | 0.39% | 48 |
|
|
2019
Q3 | $218M | Buy |
935,666
+99,476
| +12% | +$23.2M | 0.34% | 58 |
|
|
2019
Q2 | $196M | Buy |
836,190
+133,342
| +19% | +$30.8M | 0.3% | 62 |
|
|
2019
Q1 | $166M | Buy |
702,848
+13,137
| +2% | +$4.14M | 0.28% | 69 |
|
|
2018
Q4 | $208M | Buy |
689,711
+422,835
| +158% | +$135M | 0.36% | 48 |
|
|
2018
Q3 | $94.3M | Sell |
266,876
-210,943
| -44% | -$72.6M | 0.14% | 143 |
|
|
2018
Q2 | $139M | Sell |
477,819
-19,745
| -4% | -$5.55M | 0.21% | 97 |
|
|
2018
Q1 | $136M | Sell |
497,564
-43,044
| -8% | -$13.4M | 0.21% | 99 |
|
|
2017
Q4 | $172M | Sell |
540,608
-38,027
| -7% | -$12.2M | 0.23% | 91 |
|
|
2017
Q3 | $181M | Sell |
578,635
-109,860
| -16% | -$32.5M | 0.26% | 83 |
|
|
2017
Q2 | $187M | Sell |
688,495
-44,350
| -6% | -$11.7M | 0.28% | 76 |
|
|
2017
Q1 | $200M | Sell |
732,845
-13,318
| -2% | -$3.77M | 0.31% | 58 |
|
|
2016
Q4 | $212M | Sell |
746,163
-42,420
| -5% | -$12.6M | 0.34% | 50 |
|
|
2016
Q3 | $247M | Sell |
788,583
-28,841
| -4% | -$8.54M | 0.41% | 44 |
|
|
2016
Q2 | $198M | Buy |
817,424
+32,210
| +4% | +$8.49M | 0.33% | 53 |
|
|
2016
Q1 | $204M | Buy |
785,214
+111,143
| +16% | +$29.4M | 0.37% | 46 |
|
|
2015
Q4 | $207M | Sell |
674,071
-42,115
| -6% | -$12.1M | 0.37% | 49 |
|
|
2015
Q3 | $209M | Sell |
716,186
-49,768
| -6% | -$16.4M | 0.41% | 43 |
|
|
2015
Q2 | $309M | Sell |
765,954
-31,420
| -4% | -$12.6M | 0.55% | 32 |
|
|
2015
Q1 | $337M | Sell |
797,374
-33,320
| -4% | -$13.1M | 0.58% | 24 |
|
|
2014
Q4 | $282M | Sell |
830,694
-27,080
| -3% | -$8.76M | 0.51% | 35 |
|
|
2014
Q3 | $284M | Sell |
857,774
-56,348
| -6% | -$18.6M | 0.53% | 35 |
|
|
2014
Q2 | $288M | Buy |
914,122
+10,736
| +1% | +$3.23M | 0.51% | 37 |
|
|
2014
Q1 | $276M | Buy |
903,386
+895
| +0.1% | +$284K | 0.51% | 38 |
|
|
2013
Q4 | $252M | Sell |
902,491
-14,030
| -2% | -$3.63M | 0.5% | 37 |
|
|
2013
Q3 | $221M | Buy |
916,521
+7,311
| +0.8% | +$1.64M | 0.47% | 38 |
|
|
2013
Q2 | $196M | Buy |
+909,210
| New | +$194M | 0.43% | 43 |
|
Other funds holding BIIB
VCM
VPM
Prudential Financial's BIIB Position: Q1 2026 in Review
Prudential Financial reduced its Biogen (BIIB) stake by 54% in Q1 2026, selling an estimated $34.9M and leaving 163,887 shares worth $30M. The position accounts for 0.04% of the portfolio, ranked #310.
Prudential Financial first reported a position in BIIB in Q2 2013 and has held it in 52 quarters since. The position peaked at $337M in Q1 2015. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Prudential Financial held 163,887 shares of Biogen worth $30M as of Q1 2026.
- Prudential Financial sold 189,606 Biogen shares in Q1 2026, an estimated $34.9M.
- Biogen made up 0.04% of Prudential Financial's portfolio in Q1 2026, its #310 holding.
- Prudential Financial first reported a position in Biogen in Q2 2013 and has held it in 52 quarters since.
- Prudential Financial's Biogen position peaked at $337M in Q1 2015.
- 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.